A <scp>population‐based</scp> study of factors associated with systemic treatment in advanced prostate cancer decedents-Reference-Cited by-同舟云学术

A population‐based study of factors associated with systemic treatment in advanced prostate cancer decedents

Published:2022-11-17 Issue:5 Volume:12 Page:5569-5579
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Leigh Jennifer¹^ORCID,Qureshi Danial²³,Sucha Ewa²⁴,Mahdavi Roshanak⁴,Kushnir Igal⁵,Lavallée Luke T.²⁶,Bosse Dominick¹²⁷,Webber Colleen²⁸,Tanuseputro Peter¹²⁴⁸,Ong Michael¹²⁷

Affiliation:

1. Department of Medicine University of Ottawa Ottawa Ontario Canada

2. Ottawa Hospital Research Institute Ottawa Ontario Canada

3. Nuffield Department of Population Health University of Oxford England UK

4. ICES University of Ottawa, Ottawa Hospital Research Institute Ottawa Ontario Canada

5. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

6. Division of Urology, Department of Surgery The Ottawa Hospital and University of Ottawa Ottawa Ontario Canada

7. Division of Medical Oncology, Department of Medicine The Ottawa Hospital Ottawa Ontario Canada

8. Bruyère Research Institute Ottawa Ontario Canada

Funder

Institute for Clinical Evaluative Sciences

Ministry of Health

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5401

Reference41 articles.

1. Ontario Cancer Statistics 2018 Report.”2018.Cancer Care Ontario. January 8 2018.https://www.cancercareontario.ca/en/statistical‐reports/ontario‐cancer‐statistics‐2018‐report.

2. The burden of prostate cancer in Canada;Fradet Y;Can Urol Assoc J,2009

3. Characterising the castration-resistant prostate cancer population: a systematic review

4. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

5. Abiraterone and Increased Survival in Metastatic Prostate Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple therapy in metastatic hormone-sensitive prostate cancer;Current Opinion in Urology;2023-09-01

2. Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care;Current Oncology;2023-04-20